0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > CD206

CD206

Brief Information

Name:Macrophage mannose receptor 1
Target Synonym:C-type lectin domain family 13 member D,Macrophage mannose receptor 1-like protein 1,hMR,Macrophage mannose receptor 1,C-type lectin domain family 13 member D-like,CLEC13DL,MRC1L1,MRC1,Mannose Receptor C-Type 1,Mannose Receptor, C Type 1-Like 1,Human Mannose Receptor,MMR,Mannose Receptor, C Type 1,CD206 Antigen,BA541I19.1,CD206,CLEC13D,Macrophage Mannose Receptor
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:0
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

CD6-M52H7-ELISA
 CD206 ELISA

Immobilized Mannan from Saccharomyces cerevisiae at 20 μg/mL (100 μL/well) can bind Mouse CD206 Protein, His Tag (Cat. No. CD6-M52H7) with a linear range of 0.078-1.25 μg/mL (QC tested).

CD6-H82H6-MALS-HPLC
CD206 MALS images

The purity of Biotinylated Human CD206 Protein, His Tag, primary amine labeling (Cat. No. CD6-H82H6) is more than 90% and the molecular weight of this protein is around 180-210 kDa verified by SEC-MALS.

Synonym Name

MMR,CD206,hMR,MRC1,CLEC13D,CLEC13DL,MRC1L1

Background

CD209 is also known as CLEC4L, DC-SIGN and CD209 antigen. Pathogen-recognition receptor expressed on the surface of immature dendritic cells (DCs) and involved in initiation of primary immune response. On DCs it is a high affinity receptor for ICAM2 and ICAM3 by binding to mannose-like carbohydrates. May act as a DC rolling receptor that mediates transendothelial migration of DC presursors from blood to tissues by binding endothelial ICAM2. Seems to regulate DC-induced T-cell proliferation by binding to ICAM3 on T-cells in the immunological synapse formed between DC and T-cells.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Technetium Tc 99m tilmanocept NEO3-09 Approved University Of California Lymphoseek Kit, Lymphoseek, Lymphoaim United States Solid tumours; Head and Neck Neoplasms; Melanoma; Carcinoma, Squamous Cell; Breast Neoplasms; Diagnostic agents Cardinal Health 414 Llc 2013-03-13 Arthritis, Rheumatoid; Uterine Cervical Neoplasms; Sarcoma, Kaposi; Melanoma; Endometrial Neoplasms; Diagnostic agents; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Liver Neoplasms; Colonic Neoplasms; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Metabolic Dysfunction-Associated Steatotic Liver Disease; Head and Neck Neoplasms; Solid tumours; HIV Infections Details
Technetium Tc 99m tilmanocept NEO3-09 Approved University Of California Lymphoseek Kit, Lymphoseek, Lymphoaim United States Solid tumours; Head and Neck Neoplasms; Melanoma; Carcinoma, Squamous Cell; Breast Neoplasms; Diagnostic agents Cardinal Health 414 Llc 2013-03-13 Arthritis, Rheumatoid; Uterine Cervical Neoplasms; Sarcoma, Kaposi; Melanoma; Endometrial Neoplasms; Diagnostic agents; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Liver Neoplasms; Colonic Neoplasms; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Metabolic Dysfunction-Associated Steatotic Liver Disease; Head and Neck Neoplasms; Solid tumours; HIV Infections Details

This web search service is supported by Google Inc.

totop

Laisser un message